Trial intelligence / Profile preview

Citalopram effects on light-evoked brain responses in healthy volunteers

ACTRN12618000885291Phase 4Recruiting

Sponsor
Monash University
Start
Jun 2018
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of citalopram (2 arms), sponsored by Monash University. Primary endpoint: Change in suprachiasmatic area activation to light. Started Jun 2018; status: recruiting.

02

Drugs

citalopram

Beyond the preview

Go deeper on ACTRN12618000885291.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ACTRN12618000885291.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call